PURE Bioscience Partners With Italian Export Company TICE
PURE Bioscience, Inc. (NASDAQ:
the creator of the patented silver dihydrogen citrate (SDC)
antimicrobial, announced Italian export company TICE as its general
sales agent and distributor for Italy.
PURE Bioscience, Inc. (NASDAQ:PURE), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced Italian export company TICE as its general sales agent and distributor for Italy. Dosolino Marangon, Managing Partner of TICE, commented, “We are excited to introduce PURE Hard Surface and its many benefits to Italy. During the last six months we have laid the groundwork to import PURE into Italy. Our preliminary sales efforts have generated considerable interest throughout our business network, most notably in food processing, food service, retail and general commercial applications.” James McClenahan, PURE Bioscience’s Vice President of Sales, added, “We are pleased to partner with such a respected organization in Italy. TICE's ability to represent the PURE brand in a high quality manner and to leverage their many relationships across multiple industries makes it the ideal partner. We look forward to a mutually beneficial, long term partnership with Dosolino and his team at TICE.” About TICE TICE, The Italian Consortium Export, is a consortium composed of Italian companies who have as their main philosophy the promotion and sale of 100% made-in-Italy products, with an emphasis on the North American market. The product categories for TICE marketing include food and wine, production and process systems, renewable energy process systems, hospitality and restaurant decoration and design. Started on an experimental level in 2002, the TICE Consortium was officially founded in 2004 with a small number of companies. Over the years this number has grown, which has allowed TICE to create a network of business relationships in Italy, the United States and Mexico to execute innovative business concepts. About PURE Bioscience, Inc. PURE Bioscience, Inc. develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). PURE’s proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today’s global trend toward industry and consumer use of “green” products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver, which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.